000 01303 a2200397 4500
005 20250517123153.0
264 0 _c20170629
008 201706s 0 0 rus d
022 _a0004-1955
024 7 _a10.17116/patol20167859-14
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllina, D O
245 0 0 _a[Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms].
_h[electronic resource]
260 _bArkhiv patologii
_c
300 _a9-14 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAdenocarcinoma
_xmetabolism
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aApolipoproteins D
_xgenetics
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCarcinoma in Situ
_xmetabolism
650 0 4 _aCase-Control Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aProstatic Neoplasms
_xmetabolism
650 0 4 _aReceptor, EphA4
_xgenetics
700 1 _aAndreeva, Yu Yu
700 1 _aZavalishina, L E
700 1 _aMoskvina, L V
700 1 _aFrank, G A
773 0 _tArkhiv patologii
_gvol. 78
_gno. 5
_gp. 9-14
856 4 0 _uhttps://doi.org/10.17116/patol20167859-14
_zAvailable from publisher's website
999 _c26569825
_d26569825